Cingulate Inc. (NASDAQ:CING) shares are soaring Friday.
Last week, the company announced a Precision Timed Release (PTR) technology, designed to enhance ADHD drug delivery. The company’s technology aims to improve the onset and efficacy of existing ADHD treatments. Zacks Small-Cap Research also issued a note with a $70 valuation on the stock earlier this week.
Trading Volume: The stock opened at $6.63 and has traded within a day range of $6.01 to $9.69. The 50-day moving average stands at $5.81. Cingulate’s short interest has decreased by 75.73% since its last report, now at 51,000 shares, which is 3.18% of its float.
Key Metrics Recap:
- Market Cap (Previous Close): $11.12 million
- 52-Week Range: $1.80 – $187.2
- Float: 1.622 million shares
- Institutional Ownership: 1.13%
- Insider Ownership: 14.27%
How To Buy CING Stock?
In the the case of Cingulate (NASDAQ:CING), which is trading at $8.2 as of publishing time, $100 would buy you 12.2 shares of stock.
CING Price Action: Cingulate shares were up by 15% at $7.42 according to Benzinga pro.
See Also:
Image via Shutterstock.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
